University of Wisconsin Foundation Diversified Active

CIK: 0001697228 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 13, 2026

Total Value ($000): $118,931 (100.0% shares, 0.0% debt)

Holdings (8)

New Positions (2)

PCVX VAXCYTE INC 9.6%

Value ($000) $11,397 Shares 247,000 Est. Cost $44.73 Unrealized 0.0%

JANX JANUX THERAPEUTICS INC 4.2%

Value ($000) $4,996 Shares 362,000 Est. Cost $23.52 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PCVX	VAXCYTE INC	247,000	$11,397	9.6%	$44.73	0.0%	COM	92243G108
JANX	JANUX THERAPEUTICS INC	362,000	$4,996	4.2%	$23.52	0.0%	COM	47103J105

Increased Positions (3)

AAPL APPLE INC 15.0%

Value ($000) $17,791 (+77.3%) Shares 65,442 (+66.1%) Est. Cost $242.60 Unrealized +10.6%

NVDA NVIDIA CORPORATION 14.0%

Value ($000) $16,618 (+61.7%) Shares 89,106 (+61.8%) Est. Cost $178.81 Unrealized +4.1%

MSFT MICROSOFT CORP 13.2%

Value ($000) $15,683 (+55.8%) Shares 32,429 (+66.9%) Est. Cost $505.45 Unrealized -1.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
AAPL	APPLE INC	65,442 (+66.1%)	$17,791 (+77.3%)	15.0%	$242.60	+10.6%	COM	037833100
NVDA	NVIDIA CORPORATION	89,106 (+61.8%)	$16,618 (+61.7%)	14.0%	$178.81	+4.1%	COM	67066G104
MSFT	MICROSOFT CORP	32,429 (+66.9%)	$15,683 (+55.8%)	13.2%	$505.45	-1.0%	COM	594918104

Exited Positions (3)

— AKERO THERAPEUTICS INC 13.1%

Value ($000) $15,597 Shares 328,504 Est. Cost $30.03 Unrealized —

RNA AVIDITY BIOSCIENCES INC 10.6%

Value ($000) $12,600 Shares 289,201 Est. Cost $40.43 Unrealized +59.8%

MDGL MADRIGAL PHARMACEUTICALS INC 5.0%

Value ($000) $5,966 Shares 13,007 Est. Cost $202.89 Unrealized +151.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	AKERO THERAPEUTICS INC	328,504	$15,597	13.1%	$30.03	—	—	00973Y108
RNA	AVIDITY BIOSCIENCES INC	289,201	$12,600	10.6%	$40.43	+59.8%	—	05370A108
MDGL	MADRIGAL PHARMACEUTICALS INC	13,007	$5,966	5.0%	$202.89	+151.7%	—	558868105

Decreased Positions (1)

DYN DYNE THERAPEUTICS INC 6.9%

Value ($000) $8,152 (+24.5%) Shares 416,750 (-19.5%) Est. Cost $11.41 Unrealized +66.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
DYN	DYNE THERAPEUTICS INC	416,750 (-19.5%)	$8,152 (+24.5%)	6.9%	$11.41	+66.0%	COM	26818M108

Unchanged Positions (2)

PDCC PEARL DIVER CREDIT COMPANY I 17.1%

Value ($000) $20,324 Shares 1,459,021 Est. Cost $20.01 Unrealized —

NU NU HLDGS LTD 20.2%

Value ($000) $23,971 Shares 1,431,951 Est. Cost $4.46 Unrealized +260.7%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PDCC	PEARL DIVER CREDIT COMPANY I	1,459,021	$20,324	17.1%	$20.01	—	COM SHS	70476Q100
NU	NU HLDGS LTD	1,431,951	$23,971	20.2%	$4.46	+260.7%	ORD SHS CL A	G6683N103